<?xml version="1.0" encoding="UTF-8"?>
<ref id="B131">
 <label>131.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kurokawa</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Hozumi</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Tsurita</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Kadota</surname>
    <given-names>S</given-names>
   </name>
   <name>
    <surname>Namba</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Shiraki</surname>
    <given-names>K</given-names>
   </name>
  </person-group>. 
  <article-title>Biological characterization of eugeniin as an anti-herpes simplex virus type 1 compound 
   <italic>in vitro</italic> and 
   <italic>in vivo</italic>
  </article-title>. 
  <source>J Pharmacol Exp Therapeut</source>. (
  <year>2001</year>) 
  <volume>297</volume>:
  <fpage>372</fpage>â€“
  <lpage>9</lpage>. Available online at: 
  <ext-link ext-link-type="uri" xlink:href="https://europepmc.org/article/med/11259565" xmlns:xlink="http://www.w3.org/1999/xlink">https://europepmc.org/article/med/11259565</ext-link>
  <?supplied-pmid 11259565?>
  <pub-id pub-id-type="pmid">11259565</pub-id>
 </mixed-citation>
</ref>
